Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 70,000 shares at $16.66 ($1.2M) on 2016-12-01, disclosed to the SEC on 2016-12-02.
Open-market sale of $1.2M EXEL by EVP, Scientific Strategy & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EXEL | SELL | 2021-11-17 | $859K | — | Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |